Higher levels of alveolar nitric oxide in asthmatic frequent exacerbation: a pilot study. Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020
Non-adherence to inhaled corticosteroid therapy as an explanation for persistently elevated exhaled nitric oxide levels in patients with asthma: Effect of directly observed therapy with inhaled corticosteroids (DOT-ICS) Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015
Effect of montelukast treatment and withdrawal on exhaled nitric oxide and lung function in atopic asthmatic children Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007
Effect of surfactant-BL on efficiency of inhaled nitric oxide therapy in cardiac surgery patients with ARDS Source: Eur Respir J 2005; 26: Suppl. 49, 90s Year: 2005
Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD Source: Eur Respir J 2010; 35: 72-78 Year: 2010
Use of exhaled nitric oxide measurements to guide treatment in chronic asthma Source: Annual Congress 2006 - Scientific year in review Year: 2006
Effect of once-daily inhaled glucocorticosteroid administration on exhaled nitric oxide in controlled asthma patients Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008
Changes of exhaled nitric oxide during steroid treatment of childhood asthma Source: Eur Respir J 2002; 19: 1015-1019 Year: 2002
The effect of inhaled steroids on exhaled nitric oxide levels in children with idiopathic bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 181s Year: 2001
Combined inhaled nitric oxide and exogenous surfactant-BL therapy in cardiac surgery patients with ARDS Source: Eur Respir J 2005; 26: Suppl. 49, 90s Year: 2005
Clinical utility of nitric oxide metabolite level assessment in blood of patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 424s Year: 2002
Effect of oral N-acetylcysteine treatment on systemic inflammatory status in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 716s Year: 2005
Changes in nitric oxide production in patients with bronchial asthma Source: Eur Respir J 2007; 30: Suppl. 51, 588s Year: 2007
Effect of adding montelukast to budesonide treatment on exhaled nitric oxide in mild to moderate asthma Source: Eur Respir J 2004; 24: Suppl. 48, 259s Year: 2004
Feasibility of home treatment with inhaled nitric oxide for primary pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 598s Year: 2002
Inhaled corticosteroids and β2 -agonists reduces imbalance in the cellular redox status in patients with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 508s Year: 2004
Concordant reductions in total IgE and exhaled nitric oxide during oral steroid withdrawal in severe asthma at high altitude Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Features of production nitric oxide at patients with a bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006
Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013
Enhanced anti-inflammatory effects by combine inhaled nitric oxide and steroids in SARS patients and in a porcine sepsis model Source: Eur Respir J 2004; 24: Suppl. 48, 91s Year: 2004